Showing results (1311-1320 of 2,574) with videos related to
Sort By:
Pageof 258
Journal of Pediatric Surgery|September 1, 1993
Biliary tract complications in pediatric orthotopic liver transplantationM Lallier, D St-Vil, F I Luks, et al.Journal of Patient Safety|November 13, 2018
Dissecting Communication Barriers in Healthcare: A Path to Enhancing Communication Resiliency, Reliability, and Patient SafetyOren T Guttman, Elizabeth H Lazzara, Joseph R Keebler, et al.Journal of Neuroimmunology|June 12, 2003
Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patientsLaura Hartrich, Bianca Weinstock-Guttman, Dennis Hall, et al.Archives of Neurology|September 15, 2005
Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensityRobert A Bermel, Srinivas R Puli, Richard A Rudick, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 8, 2020
Conscientiousness and deterioration in employment status in multiple sclerosis over 3 yearsMichael G Jaworski, Tom A Fuchs, Michael G Dwyer, et al.Clinical Oral Investigations|October 30, 2012
Proteomic and scanning electron microscopic analysis of submandibular sialolithsJózsef Szalma, Katalin Böddi, Edina Lempel, et al.Arxiv|February 20, 2025
IRONMAP: Iron Network Mapping and Analysis Protocol for Detecting Over-Time Brain Iron Abnormalities in Neurological DiseaseJack A Reeves, Fahad Salman, Michael G Dwyer, et al.Allergy|January 6, 2025
Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic DermatitisJonathan Bar, Ester Del Duca, Eden David, et al.Journal of the Neurological Sciences|November 4, 2023
Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysisOmid Mirmosayyeb, Mohammad Yazdan Panah, Yousef Mokary, et al.Journal of the Neurological Sciences|November 18, 2023
Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) studyDejan Jakimovski, Katelyn S Kavak, Karen Zakalik, et al.Pageof 258